Olema Pharmaceuticals Inc (OLMA)
Stock chart
Loading...
•
Purchase
•
Sale
•
Planned purchase
•
Planned sale
Net purchase
Net sale
Earnings
Earnings
Value bought
Past 90 days
Value sold
Past 90 days
Net insiders buying
Past 90 days
Trades (buy and sell)
Past 90 days
Search
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
| Notification date | Transaction date | B/S Transaction type | Insider and/or position |
Nb. shares Price Value |
Number of shares | Price | Value | Details |
|---|---|---|---|---|---|---|---|---|
| 2025-01-13 | 2025-01-08 | B Purchase |
Bain Capital Life Sciences Investors, LLC Large shareholder |
300,000
+4.0%
5.76USD 1,727,370 |
300,000 +4.0% | 5.76 | USD 1,727,370 | |
| 2024-12-17 | 2024-12-17 | S Sale | Non-Executive Director |
700,761
-100.0%
6.75USD 4,730,137 |
700,761 -100.0% | 6.75 | USD 4,730,137 | |
| 2024-12-11 | 2024-12-11 | S Sale | Non-Executive Director |
179
-0.0%
9.39USD 1,681 |
179 -0.0% | 9.39 | USD 1,681 | |
| 2024-12-11 | 2024-12-11 | S Sale | Non-Executive Director |
7,958
-1.0%
8.66USD 68,916 |
7,958 -1.0% | 8.66 | USD 68,916 | |
| 2024-12-11 | 2024-12-11 | S Sale |
CH. OPERATING & FINANCIAL OFF. Officer |
406
-0.1%
9.39USD 3,812 |
406 -0.1% | 9.39 | USD 3,812 | |
| 2024-12-11 | 2024-12-11 | S Sale |
CH. OPERATING & FINANCIAL OFF. Officer |
17,950
-3.2%
8.66USD 155,447 |
17,950 -3.2% | 8.66 | USD 155,447 | |
| 2024-12-11 | 2024-12-11 | S Sale |
CH. DISCOV. & NON-CLIN DEV OFF Officer |
300
-0.1%
9.39USD 2,817 |
300 -0.1% | 9.39 | USD 2,817 | |
| 2024-12-11 | 2024-12-11 | S Sale |
CH. DISCOV. & NON-CLIN DEV OFF Officer |
13,314
-2.2%
8.66USD 115,299 |
13,314 -2.2% | 8.66 | USD 115,299 | |
| 2024-12-11 | 2024-12-11 | S Sale |
PRESIDENT AND CEO Executive Director |
1,267
-0.5%
9.39USD 11,897 |
1,267 -0.5% | 9.39 | USD 11,897 | |
| 2024-12-11 | 2024-12-11 | S Sale |
PRESIDENT AND CEO Executive Director |
55,907
-18.7%
8.66USD 484,155 |
55,907 -18.7% | 8.66 | USD 484,155 | |
| 2024-12-11 | 2024-12-11 | S Sale |
CHIEF MEDICAL OFFICER Officer |
320
-0.3%
9.39USD 3,005 |
320 -0.3% | 9.39 | USD 3,005 | |
| 2024-12-11 | 2024-12-11 | S Sale |
CHIEF MEDICAL OFFICER Officer |
14,202
-10.9%
8.66USD 122,989 |
14,202 -10.9% | 8.66 | USD 122,989 | |
| 2024-12-11 | 2024-12-10 | S Sale | Non-Executive Director |
8,256
-1.1%
9.37USD 77,359 |
8,256 -1.1% | 9.37 | USD 77,359 | |
| 2024-12-11 | 2024-12-10 | S Sale |
CH. OPERATING & FINANCIAL OFF. Officer |
16,803
-2.9%
9.37USD 157,444 |
16,803 -2.9% | 9.37 | USD 157,444 | |
| 2024-12-11 | 2024-12-10 | S Sale |
CH. DISCOV. & NON-CLIN DEV OFF Officer |
12,452
-2.0%
9.38USD 116,800 |
12,452 -2.0% | 9.38 | USD 116,800 | |
| 2024-12-11 | 2024-12-10 | S Sale |
PRESIDENT AND CEO Executive Director |
52,328
-14.9%
9.37USD 490,313 |
52,328 -14.9% | 9.37 | USD 490,313 | |
| 2024-12-11 | 2024-12-10 | S Sale |
CHIEF MEDICAL OFFICER Officer |
13,283
-9.3%
9.37USD 124,462 |
13,283 -9.3% | 9.37 | USD 124,462 | |
| 2024-08-05 | 2024-08-01 | S Sale |
Paradigm Biocapital Advisors LP Large shareholder |
529,501
-40.3%
14.92USD 7,897,507 |
529,501 -40.3% | 14.92 | USD 7,897,507 | |
| 2024-08-05 | 2024-08-01 | S Sale |
Paradigm Biocapital Advisors LP Large shareholder |
1,870,499
-28.4%
14.92USD 27,898,493 |
1,870,499 -28.4% | 14.92 | USD 27,898,493 | |
| 2024-07-31 | 2024-07-30 | PS Planned sale | Non-Executive Director |
934
-0.1%
15.55USD 14,524 |
934 -0.1% | 15.55 | USD 14,524 | |
| 2024-07-31 | 2024-07-29 | PS Planned sale | Non-Executive Director |
4,066
-0.5%
15.58USD 63,348 |
4,066 -0.5% | 15.58 | USD 63,348 | |
| 2024-07-12 | 2024-07-11 | PS Planned sale | Non-Executive Director |
5,000
-0.7%
12.26USD 61,300 |
5,000 -0.7% | 12.26 | USD 61,300 | |
| 2024-07-02 | 2024-06-28 | PS Planned sale | Non-Executive Director |
20,000
-2.6%
10.77USD 215,400 |
20,000 -2.6% | 10.77 | USD 215,400 | |
| 2024-06-06 | 2024-06-04 | S Sale | Non-Executive Director |
475,000
-40.1%
14.85USD 7,053,750 |
475,000 -40.1% | 14.85 | USD 7,053,750 | |
| 2024-06-06 | 2024-06-04 | S Sale | Non-Executive Director |
700,000
-50.0%
14.85USD 10,395,000 |
700,000 -50.0% | 14.85 | USD 10,395,000 | |
| 2024-06-04 | 2024-06-04 | PS Planned sale | Non-Executive Director |
5,000
-0.6%
12.33USD 61,650 |
5,000 -0.6% | 12.33 | USD 61,650 | |
| 2024-06-04 | 2024-06-03 | PS Planned sale | Non-Executive Director |
5,000
-0.6%
10.93USD 54,650 |
5,000 -0.6% | 10.93 | USD 54,650 | |
| 2024-06-04 | 2024-05-31 | PS Planned sale | Non-Executive Director |
15,000
-1.9%
9.41USD 141,150 |
15,000 -1.9% | 9.41 | USD 141,150 | |
| 2024-05-07 | 2024-05-06 | PS Planned sale | Non-Executive Director |
5,000
-0.6%
10.92USD 54,600 |
5,000 -0.6% | 10.92 | USD 54,600 | |
| 2024-05-02 | 2024-04-30 | PS Planned sale | Non-Executive Director |
15,000
-1.8%
9.51USD 142,650 |
15,000 -1.8% | 9.51 | USD 142,650 | |
| 2024-03-29 | 2024-03-28 | PS Planned sale | Non-Executive Director |
20,000
-2.4%
10.97USD 219,400 |
20,000 -2.4% | 10.97 | USD 219,400 | |
| 2024-03-04 | 2024-02-29 | PS Planned sale | Non-Executive Director |
100
-0.0%
13.00USD 1,300 |
100 -0.0% | 13.00 | USD 1,300 | |
| 2024-03-04 | 2024-02-29 | PS Planned sale | Non-Executive Director |
24,900
-2.9%
12.41USD 309,009 |
24,900 -2.9% | 12.41 | USD 309,009 | |
| 2024-02-02 | 2024-02-01 | PS Planned sale | Non-Executive Director |
5,000
-0.6%
15.56USD 77,800 |
5,000 -0.6% | 15.56 | USD 77,800 | |
| 2024-02-02 | 2024-01-31 | PS Planned sale | Non-Executive Director |
25,000
-2.8%
12.23USD 305,750 |
25,000 -2.8% | 12.23 | USD 305,750 | |
| 2024-01-02 | 2023-12-29 | PS Planned sale | Non-Executive Director |
2,500
-0.3%
14.10USD 35,250 |
2,500 -0.3% | 14.10 | USD 35,250 | |
| 2024-01-02 | 2023-12-29 | PS Planned sale | Non-Executive Director |
22,500
-2.4%
13.30USD 299,250 |
22,500 -2.4% | 13.30 | USD 299,250 | |
| 2023-12-08 | 2023-12-06 | B Purchase |
Paradigm Biocapital Advisors LP Large shareholder |
100,000
+1.5%
11.60USD 1,160,000 |
100,000 +1.5% | 11.60 | USD 1,160,000 | |
| 2023-12-18 | 2023-12-05 | B Purchase | Non-Executive Director |
50,000
+2.9%
13.09USD 654,250 |
50,000 +2.9% | 13.09 | USD 654,250 | |
| 2023-12-18 | 2023-12-05 | B Purchase | Non-Executive Director |
50,000
+2.9%
14.95USD 747,480 |
50,000 +2.9% | 14.95 | USD 747,480 | |
| 2023-12-18 | 2023-12-05 | B Purchase | Non-Executive Director |
31,870
+1.9%
14.73USD 469,550 |
31,870 +1.9% | 14.73 | USD 469,550 | |
| 2023-12-01 | 2023-11-30 | PS Planned sale | Non-Executive Director |
25,000
-2.6%
12.57USD 314,250 |
25,000 -2.6% | 12.57 | USD 314,250 | |
| 2023-11-22 | 2023-11-22 | S Sale | Non-Executive Director |
3,989
-0.4%
13.90USD 55,447 |
3,989 -0.4% | 13.90 | USD 55,447 | |
| 2023-11-22 | 2023-11-22 | S Sale |
CH. DISCOV. & NON-CLIN DEV OFF Officer |
6,653
-1.1%
13.89USD 92,410 |
6,653 -1.1% | 13.89 | USD 92,410 | |
| 2023-11-22 | 2023-11-22 | S Sale |
PRESIDENT AND CEO Executive Director |
27,932
-16.2%
13.90USD 388,255 |
27,932 -16.2% | 13.90 | USD 388,255 | |
| 2023-11-22 | 2023-11-22 | S Sale |
CHIEF MEDICAL OFFICER Officer |
7,095
-18.8%
13.89USD 98,550 |
7,095 -18.8% | 13.89 | USD 98,550 | |
| 2023-11-22 | 2023-11-22 | S Sale |
CH. OPERATING & FINANCIAL OFF. Officer |
9,145
-2.1%
13.89USD 127,024 |
9,145 -2.1% | 13.89 | USD 127,024 | |
| 2023-11-22 | 2023-11-21 | S Sale | Non-Executive Director |
4,192
-0.4%
14.86USD 62,293 |
4,192 -0.4% | 14.86 | USD 62,293 | |
| 2023-11-22 | 2023-11-21 | S Sale |
CH. DISCOV. & NON-CLIN DEV OFF Officer |
200
-0.0%
15.32USD 3,064 |
200 -0.0% | 15.32 | USD 3,064 | |
| 2023-11-22 | 2023-11-21 | S Sale |
CH. DISCOV. & NON-CLIN DEV OFF Officer |
6,776
-1.2%
14.87USD 100,759 |
6,776 -1.2% | 14.87 | USD 100,759 | |
| 2023-11-22 | 2023-11-21 | S Sale |
PRESIDENT AND CEO Executive Director |
2,602
-1.5%
15.29USD 39,785 |
2,602 -1.5% | 15.29 | USD 39,785 | |
| 2023-11-22 | 2023-11-21 | S Sale |
PRESIDENT AND CEO Executive Director |
26,691
-13.2%
14.84USD 396,094 |
26,691 -13.2% | 14.84 | USD 396,094 | |
| 2023-11-22 | 2023-11-21 | S Sale |
CHIEF MEDICAL OFFICER Officer |
200
-0.5%
15.33USD 3,066 |
200 -0.5% | 15.33 | USD 3,066 | |
| 2023-11-22 | 2023-11-21 | S Sale |
CHIEF MEDICAL OFFICER Officer |
7,261
-16.1%
14.83USD 107,681 |
7,261 -16.1% | 14.83 | USD 107,681 | |
| 2023-11-22 | 2023-11-21 | S Sale |
CH. OPERATING & FINANCIAL OFF. Officer |
700
-0.2%
15.27USD 10,689 |
700 -0.2% | 15.27 | USD 10,689 | |
| 2023-11-22 | 2023-11-21 | S Sale |
CH. OPERATING & FINANCIAL OFF. Officer |
8,897
-2.0%
14.83USD 131,943 |
8,897 -2.0% | 14.83 | USD 131,943 | |
| 2023-11-13 | 2023-11-08 | PS Planned sale |
CH. DISCOV. & NON-CLIN DEV OFF Officer |
200
-0.0%
17.61USD 3,522 |
200 -0.0% | 17.61 | USD 3,522 | |
| 2023-11-03 | 2023-11-03 | PS Planned sale |
CH. DISCOV. & NON-CLIN DEV OFF Officer |
541
-0.1%
17.51USD 9,473 |
541 -0.1% | 17.51 | USD 9,473 | |
| 2023-11-03 | 2023-11-02 | PS Planned sale |
CH. DISCOV. & NON-CLIN DEV OFF Officer |
3,332
-0.6%
15.36USD 51,180 |
3,332 -0.6% | 15.36 | USD 51,180 | |
| 2023-11-02 | 2023-11-02 | PS Planned sale | Non-Executive Director |
5,000
-0.5%
15.64USD 78,200 |
5,000 -0.5% | 15.64 | USD 78,200 | |
| 2023-11-03 | 2023-11-01 | PS Planned sale |
CH. DISCOV. & NON-CLIN DEV OFF Officer |
6,668
-1.2%
15.02USD 100,153 |
6,668 -1.2% | 15.02 | USD 100,153 | |
| 2023-11-02 | 2023-10-31 | PS Planned sale | Non-Executive Director |
25,000
-2.6%
12.05USD 301,250 |
25,000 -2.6% | 12.05 | USD 301,250 | |
| 2023-10-03 | 2023-09-29 | PS Planned sale | Non-Executive Director |
25,000
-2.5%
12.41USD 310,250 |
25,000 -2.5% | 12.41 | USD 310,250 | |
| 2023-09-21 | 2023-09-19 | PS Planned sale |
CH. DISCOV. & NON-CLIN DEV OFF Officer |
20,000
-3.4%
12.67USD 253,400 |
20,000 -3.4% | 12.67 | USD 253,400 | |
| 2023-12-18 | 2023-09-12 | B Purchase | Non-Executive Director |
508,130
+43.8%
9.84USD 4,999,999 |
508,130 +43.8% | 9.84 | USD 4,999,999 | |
| 2023-09-14 | 2023-09-12 | B Purchase | Non-Executive Director Large shareholder |
52,801
+11.2%
9.84USD 519,562 |
52,801 +11.2% | 9.84 | USD 519,562 | |
| 2023-09-14 | 2023-09-12 | B Purchase | Non-Executive Director Large shareholder |
677,853
+23.3%
9.84USD 6,670,074 |
677,853 +23.3% | 9.84 | USD 6,670,074 | |
| 2023-09-14 | 2023-09-12 | B Purchase | Non-Executive Director Large shareholder |
775,278
+19.8%
9.84USD 7,628,736 |
775,278 +19.8% | 9.84 | USD 7,628,736 | |
| 2023-09-05 | 2023-09-05 | PS Planned sale | Non-Executive Director |
10,000
-1.0%
11.62USD 116,200 |
10,000 -1.0% | 11.62 | USD 116,200 | |
| 2023-09-05 | 2023-08-31 | PS Planned sale | Non-Executive Director |
15,000
-1.5%
9.36USD 140,400 |
15,000 -1.5% | 9.36 | USD 140,400 | |
| 2023-08-17 | 2023-08-16 | PS Planned sale | Non-Executive Director |
15,000
-1.4%
10.14USD 152,100 |
15,000 -1.4% | 10.14 | USD 152,100 | |
| 2023-06-09 | 2023-06-08 | S Sale | Non-Executive Director |
10,000
-1.0%
6.30USD 63,000 |
10,000 -1.0% | 6.30 | USD 63,000 | |
| 2023-06-07 | 2023-06-06 | S Sale | Non-Executive Director |
5,000
-0.5%
6.30USD 31,475 |
5,000 -0.5% | 6.30 | USD 31,475 | |
| 2023-06-07 | 2023-06-05 | PS Planned sale | Non-Executive Director |
5,000
-0.5%
6.05USD 30,225 |
5,000 -0.5% | 6.05 | USD 30,225 | |
| 2023-04-07 | 2023-04-06 | PP Planned purchase |
CH. OPERATING & FINANCIAL OFF. Officer |
10,000
0.00USD 0 |
10,000 | 0.00 | USD 0 |